))
What is the Value of Early Detection of Dementia?
Manage episode 446201005 series 3609642
Content provided by Michigan Medicine Department of Communication and Michigan Medicine Podcast Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Michigan Medicine Department of Communication and Michigan Medicine Podcast Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode we talk with Dr. Ken Langa about the implications of identification of “preclinical” Alzheimer’s disease (situations where individuals may have biological signs of Alzheimer’s but no symptoms). Ken is a leading dementia researcher and our discussion focuses on an article he published called “Preclinical Alzheimer Disease – Early Diagnosis or Overdiagnosis” that was published in JAMA Internal Medicine. In his article co-authored with Dr. Jim Burke, he brings up some of the potential indirect effects of early detection.
The transcript for this episode can be found here.
RELATED LINKS:
- CAPRA Website: http://capra.med.umich.edu/
- National Poll on Healthy Aging: https://www.healthyagingpoll.org/
- Article discussed in this episode: https://pubmed.ncbi.nlm.nih.gov/31282928/ Langa, Kenneth M., and James F. Burke. "Preclinical Alzheimer disease—early diagnosis or overdiagnosis?." JAMA Internal Medicine 179.9 (2019): 1161-1162.
You can subscribe to Minding Memory on Apple Podcasts, Spotify, Google Podcasts or wherever you listen to podcasts.
Hosted on Acast. See acast.com/privacy for more information.
40 episodes
Share
